Value of Transcutaneous Bilirubin Devices

NCT06232174 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-07-30

No results posted yet for this study

Summary

The goal of this observational study is to compare the value of transcutaneous bilirubin devices versus serum bilirubin in jaundiced neonates

Conditions

  • Jaundice

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mohammed Gamil, Professor · Assiut University

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-31
Primary Completion
2025-01-31
Completion
2025-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06232174 on ClinicalTrials.gov